Tag: Cancer: Lung
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
Rate of New Lung Cancer Cases Has Decreased Over Last Five Years
26.6 percent of people alive five years after a lung cancer diagnosis, with 22 percent improvement seen over last five years
2023 Guidelines Update Eligibility for Lung Cancer Screening
Updated guidelines recommend annual screening for those aged 50 to 80 years who currently smoke, or formerly smoked
Occupational Exposure to Dust: Health Problems & Safety Tips
Incidence of Lung Cancer Higher in Women Versus Men Aged 35 to 54 Years
Female-to-male incidence rate ratio increased from 0.73 during 2000 to 2004 to 1.05 during 2015 to 2019
ASTRO: Liquid Biopsy Can Stratify Risk in Oligometastatic NSCLC
Overall, progression-free survival worse for oligometastatic NSCLC patients with versus without detectable ctDNA before radiotherapy
PLCOm2012 Models Have High Sensitivity for Lung Cancer
PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification
Machine Learning Can Better ID Who Needs Lung Cancer Screening
Model relies only on age, smoking duration, and pack-years
Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy
Reproductive Factors Linked to Risk for Lung Cancer
Early menarche, early menopause, shortened reproductive life span linked to increased risk, especially for NSCLC
